EXOZ - NASDAQ

eXoZymes, Inc.

EXOZ·NASDAQ

$9.46

-2.2%

HealthcareBiotechnology

eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$80.21M

EPS-1.0900

P/E Ratio-8.68

Earnings Date05/14/2026

exoz

Other Current Assets

Last Annual Value

382.89K

3-Year CAGR

56%

5-Year CAGR

66%

10-Year CAGR

29%

Adjust for Inflation

eXoZymes, Inc. Competitors Analysis of Other Current Assets

EXOZ · NASDAQ

Company	Other Current Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
eXoZymes, Inc. NASDAQ:EXOZ	382.89K	13.1%	66.2%	N/A
aTyr Pharma, Inc. NASDAQ:ATYR	0.00	N/A	N/A	N/A
MacroGenics, Inc. NASDAQ:MGNX	8.74M	-4.2%	N/A	28.7%
Metagenomi, Inc. Common Stock NASDAQ:MGX	4.43M	-1.5%	74.8%	N/A
Zentalis Pharmaceuticals, Inc. NASDAQ:ZNTL	5.37M	-27.0%	N/A	N/A
Quince Therapeutics, Inc. NASDAQ:QNCX	84.00K	1.2%	-25.5%	N/A
Atossa Therapeutics, Inc. NASDAQ:ATOS	4.32M	64.1%	27.1%	54.7%
Anebulo Pharmaceuticals, Inc. NASDAQ:ANEB	0.00	N/A	N/A	N/A
Instil Bio, Inc. NASDAQ:TIL	114.45M	324.0%	N/A	N/A
Greenwich LifeSciences, Inc. NASDAQ:GLSI	0.00	N/A	N/A	N/A
Tevogen Bio Holdings Inc. NASDAQ:TVGN	919.09K	N/A	76.3%	N/A

eXoZymes, Inc. Fair Value Envelope

EXOZ · NASDAQ

Our analysis suggests that EXOZ has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $9.46, this represents a potential HIDDEN relative to our calculated worth for eXoZymes, Inc..

HIDDEN

Intrinsic Value

Current Price: $9.46

Related Guides

Blog Categories

Continue your EXOZ research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.